High expression of podoplanin was demonstrated in primary brain tumors and contributed to platelet aggregation and hypercoagulability state, suggesting the potential antitumor role of podoplanin inhibitors in glioblastoma [234]. This evidence concerns the gene PDPN and glioblastoma.